Your browser doesn't support javascript.
loading
High TGF-ß signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition.
Ni, Ying; Soliman, Ahmed; Joehlin-Price, Amy; Rose, Peter G; Vlad, Anda; Edwards, Robert P; Mahdi, Haider.
Afiliação
  • Ni Y; Center for Immunotherapy and Precision Immuno-Oncology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
  • Soliman A; Department of Pediatrics, Case Western University, 2103 Cornell Rd, Cleveland, OH, 44106, USA.
  • Joehlin-Price A; Department of Anatomic Pathology, Pathology and Laboratory Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
  • Rose PG; Section of Gynecologic Oncology, Women's Health Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
  • Vlad A; Magee Women's Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.
  • Edwards RP; Magee Women's Research Institute, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
  • Mahdi H; Magee Women's Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA.
NPJ Precis Oncol ; 5(1): 101, 2021 Dec 17.
Article em En | MEDLINE | ID: mdl-34921236
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article